Results 121 to 130 of about 39,119 (216)

Lefamulin or moxifloxacin for community-acquired pneumonia: balancing innovation, safety, and evidence. [PDF]

Ann Med Surg (Lond)
Wasti SA, Wasti A, Iqbal MU, Danaf N.
europepmc   +1 more source

Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trial. [PDF]

EClinicalMedicine
File TM, Kaye KS, Ihor S, Hovbakh I, Katsarava V, Kirsch C, Soni K, Gupta K, Manley A, Deck DH, Anastasiou D, Chitra S, Villano S.   +12 more
europepmc   +1 more source

Post anaphylactic shock myocardial infarction (Kounis syndrome): a rare case report. [PDF]

Ann Med Surg (Lond)
Abadi A, Ghanem U, Nierat S, Joma M.
europepmc   +1 more source

Verapamil Suppresses the Development of Resistance Against Anti-Tuberculosis Drugs in Mycobacteria. [PDF]

Int J Mol Sci
Liu K, Buitenhek E, Kuijl CP, Mulla Y, Luirink J, Bald D.   +5 more
europepmc   +1 more source

Hemorrhagic risk of concomitant direct oral anticoagulants and fluoroquinolones: integration of pharmacovigilance and therapeutic drug monitoring. [PDF]

Front Pharmacol
Xu J, Li YD, Han JP, Duan CY, Zhao FL, Shang ZY, Zhu Z, Hu ZH.   +7 more
europepmc   +1 more source

A Review of Moxifloxacin for the Treatment of Drug‐Susceptible Tuberculosis

Journal of clinical pharmacology, 2017
A. Naidoo, K. Naidoo, H. McIlleron, S. Essack, N. Padayatchi   +4 more
semanticscholar   +1 more source

Acceptability of 100-mg moxifloxacin in children with rifampicin-resistant TB in three high-burden countries. [PDF]

IJTLD Open
Suryavanshi N, Draper HR, Dhumal G, Bagchi S, Castillo-Carandang NT, Marthinus A, Cheong AMA, Kinikar A, Paradkar M, Gupta A, Ocampo JDR, Frias MVG, Casalme DJO, Hesseling A, Garcia-Prats AJ, Palmer M, Hoddinott G, Viljoen L, CATALYST Trial Team.   +18 more
europepmc   +1 more source

Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB

Journal of Antimicrobial Chemotherapy, 2017
A. Naidoo, M. Chirehwa, H. McIlleron, K. Naidoo, S. Essack, N. Yende-Zuma, Eddy Kimba-Phongi, John H Adamson, Katya Govender, N. Padayatchi, P. Denti   +10 more
semanticscholar   +1 more source

A Thorough QT Study to Assess the Effects of Milvexian on Cardiac Repolarization in Healthy Participants. [PDF]

Clin Pharmacol Drug Dev
Zannikos P, Park J, Dari A, Takhtoukh S, Levesque P, Plotnikov AN, Mitra A, Ajavon-Hartmann A, Merali S, Perez Ruixo JJ, Goyal N.   +10 more
europepmc   +1 more source

Immediate moxifloxacin hypersensitivity: Is there more than currently meets the eye?

Allergy. European Journal of Allergy and Clinical Immunology, 2017
A. L. Gasse, V. Sabato, A. Uyttebroek, J. Elst, M. Faber, M. Hagendorens, Christel M Mertens, C. Bridts, L. S. Clerck, D. Ebo   +9 more
semanticscholar   +1 more source